Mancini SJ et al.Canagliflozin inhibits interleukin-1ß-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.Sci Rep 8:5276 (2018).
Dite TA et al.The autophagy initiator ULK1 sensitizes AMPK to allosteric drugs.Nat Commun 8:571 (2017).
Bizjak M et al.Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro.Sci Rep 7:1761 (2017).
Webb TJ et al.Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.Pathog Dis 74:N/A (2016).
Head SA et al.Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.Proc Natl Acad Sci U S A 112:E7276-85 (2015).
Yan Y et al.SUMOylation of AMPKa1 by PIAS4 specifically regulates mTORC1 signalling.Nat Commun 6:8979 (2015).
Vincent EE et al.Differential effects of AMPK agonists on cell growth and metabolism.Oncogene : (2014).
Chen Z et al.Promotion of adiponectin multimerization by emodin, a novel AMPK activator with PPAR?-agonist activity.J Cell Biochem : (2012).
Galic S et al.Hematopoietic AMPK ß1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity.J Clin Invest 121:4903-15 (2011).